Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 4, 2008
Medical burden in late-life bipolar and major depressive disorders
Ariel G Gildengers, Ellen M Whyte, Rebecca A Drayer, et al.
Journal of Clinical Psychopharmacology
|
August 17, 2022
Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis
Argyrios Perivolaris, Nicholas J Ainsworth, George S Alexopoulos, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
August 1, 2008
An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients
Ellen M Whyte, Eric J Lenze, Meryl Butters, et al.
Journal of Affective Disorders
|
June 18, 2019
Health-related quality of life in remitted psychotic depression<sup>✰</sup>
Kathleen S Bingham, Ellen M Whyte, Benoit H Mulsant, et al.
Journal of Affective Disorders
|
May 23, 2026
Effect of continuation treatment on health-related quality of life in remitted psychotic depression
Ryma A Bendel, George S Alexopoulos, Patricia Marino, et al.
Psychiatry Research
|
September 19, 2024
Predictors of attrition during acute pharmacotherapy of psychotic depression in a clinical trial
Ryma A Ihaddadene, George S Alexopoulos, Patricia Marino, et al.
Journal of Affective Disorders
|
April 5, 2025
Prediction of remission of pharmacologically treated psychotic depression: A machine learning approach
Emily Carter, Samprit Banerjee, George S Alexopoulos, et al.
JAMA Psychiatry
|
February 27, 2020
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial
Aristotle N Voineskos, Benoit H Mulsant, Erin W Dickie, et al.
JAMA
|
August 21, 2019
Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial
Alastair J Flint, Barnett S Meyers, Anthony J Rothschild, et al.
Ebiomedicine
|
October 6, 2018
Resting state functional connectivity in patients with remitted psychotic depression: A multi-centre STOP-PD study
Nicholas H Neufeld, Benoit H Mulsant, Erin W Dickie, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
March 4, 2008
Medical burden in late-life bipolar and major depressive disorders
Ariel G Gildengers, Ellen M Whyte, Rebecca A Drayer, et al.
Journal of Clinical Psychopharmacology
|
August 17, 2022
Placebo Effect in Randomized Trials of Major Depressive Disorder With Psychotic Features: A Systematic Review and Descriptive Meta-Analysis
Argyrios Perivolaris, Nicholas J Ainsworth, George S Alexopoulos, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
August 1, 2008
An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients
Ellen M Whyte, Eric J Lenze, Meryl Butters, et al.
Journal of Affective Disorders
|
June 18, 2019
Health-related quality of life in remitted psychotic depression<sup>✰</sup>
Kathleen S Bingham, Ellen M Whyte, Benoit H Mulsant, et al.
Journal of Affective Disorders
|
May 23, 2026
Effect of continuation treatment on health-related quality of life in remitted psychotic depression
Ryma A Bendel, George S Alexopoulos, Patricia Marino, et al.
Psychiatry Research
|
September 19, 2024
Predictors of attrition during acute pharmacotherapy of psychotic depression in a clinical trial
Ryma A Ihaddadene, George S Alexopoulos, Patricia Marino, et al.
Journal of Affective Disorders
|
April 5, 2025
Prediction of remission of pharmacologically treated psychotic depression: A machine learning approach
Emily Carter, Samprit Banerjee, George S Alexopoulos, et al.
JAMA Psychiatry
|
February 27, 2020
Effects of Antipsychotic Medication on Brain Structure in Patients With Major Depressive Disorder and Psychotic Features: Neuroimaging Findings in the Context of a Randomized Placebo-Controlled Clinical Trial
Aristotle N Voineskos, Benoit H Mulsant, Erin W Dickie, et al.
JAMA
|
August 21, 2019
Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial
Alastair J Flint, Barnett S Meyers, Anthony J Rothschild, et al.
Ebiomedicine
|
October 6, 2018
Resting state functional connectivity in patients with remitted psychotic depression: A multi-centre STOP-PD study
Nicholas H Neufeld, Benoit H Mulsant, Erin W Dickie, et al.
Page
of 9